News

not found

Boss of Indonesia cough syrup maker jailed after child deaths

The boss and three other officials of an Indonesian firm whose cough syrup was linked to the deaths of over 200 children have been sentenced to jail. They were handed two-year prison sentences and fined 1bn Indonesian rupiah ($63,056; £51,786). The firm, Afi Farma, was accused of producing cough syrups containing excess amounts of toxic substances. The company's lawyer said they denied negligence and the firm was considering whether to appeal. Prosecutors had been seeking a prison sentence of up to nine years for Afi Farma's chief executive, Arief Prasetya Harahap, and seven years each for the other defendants. The Public Prosecutor said that between October 2021 and February 2022 the company received two batches of propylene glycol, which is used for making cough syrup. These batches contained 96% to 99% ethylene glycol, the prosecutor said. Both substances can be used as additives to solvents. While, propylene glycol is non-toxic and widely used in medicines, cosmetics and food, ethylene glycol is toxic and used in paint, pens and brake fluid. The company did not test the ingredients used in the cough syrup and instead relied on quality and safety certificates from its supplier, prosecutors said. Afi Farma's lawyer, Samsul Hidayat, told the BBC that Indonesia's drug regulator did not require drug makers to carry out rigorous testing of ingredients. The judge in the Kediri District Court, East Java, found the four defendants guilty of intentionally producing pharmaceutical goods that did not meet safety standards. The case comes as efforts grow worldwide to tighten the oversight of drug supply chains after the poisonings. Since 2022, more than 200 Indonesian children, most of whom were under the age of five, have died of acute kidney injury linked to contaminated cough syrup. About 100 deaths have been reported in The Gambia and Uzbekistan. The World Health Organization (WHO) has issued warnings about six cough syrups made in India and Indonesia.

  • 7 November, 12:07
  • Read more
not found

Startup’s Oxygen-Boosting ‘Artificial Lung’ Receives US Patent

Inspira Technologies has developed a machine that can raise a patient's oxygen saturation to 95 percent or higher almost immediately (Courtesy) A new device developed by an Israeli startup that helps patients breathe when their lungs are unable to do so fully has just been patented in the US. The INSPIRA ART500, produced by Inspira Technologies, is a small box-shaped device that acts as an artificial lung. It draws small volumes of blood with low oxygen levels from patients and circulates it, enriches it with oxygen and removes carbon dioxide, and sends it back through a tube inserted into the neck.  The startup has developed the device with the aim of reducing the need for mechanical ventilation systems. According to the company, these systems are associated with a 50 percent mortality rate, can heighten the risk of coma and even cause bacterial infections or other associated lung injuries related to mechanical ventilation.  The newly granted patent relates to the module of the machine that prevents air bubbles within its pumps, thereby reducing the risk of the formation of clots which reduce blood flow.  Inspira has also initiated patent applications in Europe and several countries in other regions. “We believe that this patent approval represents a further recognition of our unique solution alongside a major milestone towards the INSPIRA ART500 system and building a global medical solution,” said Dagi Ben-Noon, CEO of Inspira. “We are working diligently to convert our innovation into value for our shareholders.”

  • 6 November, 12:50
  • Read more
not found

Cooperation with Afghanistan in the field of pharmaceuticals will expand

The delegation led by the Deputy Prime Minister of Uzbekistan Jamshid Khodjaev visited Kabul to further develop cooperation with the Islamic Emirate of Afghanistan.The "Made in Uzbekistan" exhibition organized at the International Business Center was attended by a group of industry officials under the leadership of Abdulla Azizov, director of the Pharmaceutical Industry Development Agency. More than 300 medical products were displayed. Also, meetings and negotiations were held in "B2B" format between representatives of the business circles of the two countries. About 4,000 medical products were presented at the exhibition.Director of the Pharmaceutical Service of the Ministry of Health of Afghanistan, Hamid Formuloy, made suggestions on simplifying the registration of the delivery of pharmaceuticals and products produced in Uzbekistan to Afghanistan.In this matter, practical assistance will be provided to establish cooperation with the National Association of Food and Medicines of Afghanistan, which has the authority to register medical products.Within the framework of the meetings, the issue of importing medicines, medical equipment and medical equipment from our country to private hospitals in this country and sending patients to Uzbekistan for treatment was discussed with the deputy of the Afghanistan Entrepreneurs' Advisory Council for health issues, Dr. Muhammad Hashim Wahaaj. Also, an agreement was reached on the visit of the Afghan delegation in order to get acquainted with medical products and treatment processes in Uzbekistan. Export-import issues were discussed with Zabihullah Momen Zada, a member of the Kabul Chamber of Commerce and Industry.

  • 31 October, 11:07
  • Read more
Нажмите на кнопку ниже, чтобы прослушать текст Powered by GSpeech